Ekso Bionics Holdings, Inc. (EKSO) develops wearable exoskeleton technology for medical rehabilitation and industrial applications. The company demonstrates strong compliance in debt (5.96%) and liquidity (8.54%) ratios across all standards, with no non-permissible business income identified. However, the interest income ratio of 12.74% exceeds the 5% threshold, leading to financial non-compliance. Business activities are largely permissible, with minor defense-related revenue (<5%) requiring purification. Overall, based on index exclusions, the stock is non-compliant but could become suitable with income purification and monitoring.